Euclid Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-845,240
Closed -$7.11M 278
2016
Q2
$7.11M Buy
845,240
+821,740
+3,497% +$6.6M 0.31% 114
2016
Q1
$194K Sell
23,500
-7,400
-24% -$53.8K 0.01% 424
2015
Q4
$245K Buy
+30,900
New +$232K 0.01% 429
2015
Q3
Sell
-1,408,920
Closed -$11.5M 351
2015
Q2
$11.5M Buy
+1,408,920
New +$11.1M 0.23% 147
2015
Q1
Sell
-546,140
Closed -$4.33M 373
2014
Q4
$4.33M Buy
546,140
+24,590
+5% +$191K 0.04% 302
2014
Q3
$3.9M Buy
521,550
+38,800
+8% +$277K 0.03% 412
2014
Q2
$3.26M Sell
482,750
-139,100
-22% -$831K 0.02% 434
2014
Q1
$3.42M Buy
621,850
+160,600
+35% +$853K 0.03% 369
2013
Q4
$2.51M Sell
461,250
-30,300
-6% -$159K 0.02% 477
2013
Q3
$2.52M Buy
+491,550
New +$2.4M 0.03% 433

Other funds holding LRCX

Euclid Advisors's LRCX Position: Q3 2016 in Review

Euclid Advisors sold out of Lam Research (LRCX) in Q3 2016, closing a stake of 845,240 shares — an estimated $7.11M sold.

Euclid Advisors first reported a position in LRCX in Q3 2013 and held it in 10 quarters. The position peaked at $11.5M in Q2 2015. 605 funds tracked by Wall St. Rank hold LRCX as of Q3 2016.

  • Euclid Advisors reported no remaining Lam Research position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 845,240 Lam Research shares in Q3 2016, an estimated $7.11M.
  • Euclid Advisors first reported a position in Lam Research in Q3 2013 and held it in 10 quarters.
  • Euclid Advisors's Lam Research position peaked at $11.5M in Q2 2015.
  • 605 funds tracked by Wall St. Rank held Lam Research as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.